Regulatory Exclusivity: PATENT CHALLENGE
✉ Email this page to a colleague
Drugs with Patent Challenge Regulatory Exclusivity
Click here to include patents covering these drugs in this list
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Exclusivity Expiration | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-001 | Jun 10, 2016 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-002 | Jun 10, 2016 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-003 | Jun 10, 2016 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
Apotex | DASATINIB | dasatinib | TABLET;ORAL | 203180-001 | Nov 23, 2021 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-004 | Jun 10, 2016 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
Ingenus Pharms Llc | IVABRADINE HYDROCHLORIDE | ivabradine hydrochloride | TABLET;ORAL | 214051-001 | Dec 30, 2021 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
Ingenus Pharms Llc | IVABRADINE HYDROCHLORIDE | ivabradine hydrochloride | TABLET;ORAL | 214051-002 | Dec 30, 2021 | AB | RX | No | No | ⤷ Try for Free | PATENT CHALLENGE |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Exclusivity Expiration | >Patented / Exclusive Use |